| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Director, 10% Owner
4 companies
Canaan X L.P. is a 10% Owner at IDEAYA Biosciences, Inc. with holdings across 4 companies. Recent SEC Form 4 filings include 4 buys and 13 sells.
Estimated insider holdings value: $306.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 28, 2019 | IDYA Ideaya Biosciences, Inc. | 10% Owner | Buy | 400,000 | $10.00 | $4,000,000.00 | +17.7% | |
| May 13, 2019 | NXTC Nextcure, Inc. | 10% Owner | Buy | 50,000 | $15.00 | $750,000.00 | +2.3% | |
| May 30, 2018 | ITRM Iterum Therapeutics Plc | Director, 10% Owner | Buy | 506,656 | $13.00 | $6,586,528.00 | +41.3% | |
| May 17, 2018 | PTGX Protagonist Therapeutics, Inc | 10% Owner | Sell | 38,968 | $6.09 | $237,357.98 | -1.8% | |
| May 16, 2018 | PTGX Protagonist Therapeutics, Inc | 10% Owner | Sell | 164,747 | $6.42 | $1,058,374.50 | -2.4% | |
| Mar 23, 2018 | PTGX Protagonist Therapeutics, Inc | 10% Owner | Sell | 59,950 | $20.71 | $1,241,324.70 | -2.5% | |
| Mar 22, 2018 | PTGX Protagonist Therapeutics, Inc | 10% Owner | Sell | 39,518 | $20.61 | $814,398.15 | -0.5% | |
| Mar 19, 2018 | PTGX Protagonist Therapeutics, Inc | 10% Owner | Sell | 20,365 | $20.55 | $418,508.25 | -0.4% | |
| Mar 15, 2018 | PTGX Protagonist Therapeutics, Inc | 10% Owner | Sell | 13,155 | $20.66 | $271,768.43 | -0.2% | |
| Aug 16, 2016 | PTGX Protagonist Therapeutics, Inc | Director, 10% Owner | Buy | 583,333 | $12.00 | $6,999,996.00 | +31.2% |